Get Rich with Atossa Therapeutics Stock ATOS | Atossa Therapeutics Stock Analysis & Earnings

Today we take another look at the Atossa Therapeutics stock, to see why this is now an even better investment opportunity than before. We see that ATOS has stabilised, after falling for a while and is back at its end of January levels. So this stabilisation could indicate a great time to buy. ⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯ Check Out FBE Favourites on IG if you Appreciate High Quality Products ⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯⋯ ✔ INSTAGRAM ► https://www.instagram.com/fbe_favourites ✔ FACEBOOK ► https://www.facebook.com/financebankingexplained ___________________________________________ PREVIOUS - VIDEO: Guaranteed GAINS with Coca Cola Stock ► /watch/M0lOhYEIHodIO This is further supported by the fact that, the reason why the Atossa stock doubled in less than a week in the beginning of February, was because a major breakthrough in the Endoxifin research and this has not changed. Atossa Therapeutics is still going full speed ahead with further development of this revolutionary therapy. But as with most penny stocks in the bio tech industry, when the hype dies down there tends to be a sell off, since the business is not yet generating any significant revenue streams, while having huge R&D costs. With companies like these you don’t invest in solid financials, you invest in a revolutionary product, that is being developed and this takes time and money to realise. When we look at the performance of the stock for the past year, we see that ATOS is still up over 36%. So even though it’s a volatile stock, it’s still providing a nice return. This return will only keep growing as more trials are completed and we get closer to a final product. Video Structure: 00:00 Intro 00:40 ATOS Stock Performance 01:59 Major Investment Opportunity 03:34 Endoxifen Market Size 04:39 Atossa Financial Performance 05:28 Atossa Therapeutics Competitive Advantage 06:44 ATOS Share Price Outlook So why is now, a prefect time to invest in Atossa Therapeutics? Well the answer to this, lies in the start of the Oral Endoxifin MBD trial, that the company is currently setting up in Sweden. Here Atossa Therapeutics will test the oral use of Endoxfin in reducing the mammographic breast density, also known as MBD. #Atossa #StocksToBuy #StockMarket #atossastock #atos #pennystock #stockanalysis #stocktrading #atossatherapeutics #atossanews Disclaimer The value of investments can up as well as down. Buy and Sell at your own discretion and always act with prudence when making investment decisions. The income derived from this is not guaranteed. Make sure you have a well balanced and diversified portfolio. This will limit your exposure to fluctuations in a specific security. So this means spreading out your investments across, money market funds, low risk ETF’s, stable high yield dividend stocks, growth stocks and if you want the added risk, you could opt for forex, crypto and volatile penny stocks. Never invest all you savings or all your monthly/yearly income, but only the money you can offered to lose. About - Finance & Banking Explained We dive into the world of international finance and banking, providing financial advise on a whole host of issues including, financing, banking, lending, mortgages, investing, trading, forex, borrowing, debt, credit & credit cards, passive income, regulations, and many more subjects. Seattle 2021/2022

Category